Title: Structural identification and characterization of impurities in ceftizoxime sodium.
Journal: Journal of pharmaceutical and biomedical analysis 20070117
24701-69-7
26395-99-3
70287-30-8
79349-82-9
15690-38-7
103121-85-3
380336-87-8 | 2-[4-(Benzyloxy)phenoxy]acetohydrazide | AA00I7EG | MFCD01112517
38401-41-1 | (1-Methylcyclobutyl)methanol | AA00I7KH | MFCD18072623
39640-05-6 | Piperazin-1-yl(pyridin-4-yl)methanone dihydrochloride | AA00I7PU | MFCD06800823
40594-30-7 | 2,4-Difluorophenylhydrazine | AA00I7VW | MFCD00042256
41791-10-0 | 1-(Bromomethyl)-4-methylnaphthalene | AA00I829 | MFCD12025363
43120-31-6 | 4,6-Dimethyl-1H-indazole | AA00I883 | MFCD07781501
4474-86-6 | Z-D-Asn-OH | AA00I8DV | MFCD00065696
468747-44-6 | (Z)-4-(3,4-Dimethoxyphenylamino)-4-oxobut-2-enoic acid | AA00I8IL | MFCD01185849
481-29-8 | Androstan-17-one, 3-hydroxy-, (3b,5a)- | AA00I8OJ | MFCD00064134
499227-78-0 | 2-(1H-Benzoimidazol-2-yl)-4,5-dichloro-2h-pyridazin-3-one | AA00I8TY | MFCD03948593